Life, Volume 14, Issue 3
2024 March - 142 articles
Cover Story: Immunotherapy has emerged as a promising strategy, harnessing the body’s immune system to combat gynecological cancer. This literature review provides a comprehensive overview of the current landscape and future directions of immunotherapy in cervical and endometrial cancer. It presents the most critical methods and treatments employed in immunotherapy for cervical and endometrial cancer, including immune checkpoint inhibitors, cancer vaccines, and adoptive cell therapies. Immune checkpoint inhibitors, such as anti-PD-1/PD-L1 antibodies, have shown remarkable clinical efficacy in certain gynecological malignancies, particularly in advanced or recurrent cases. Ongoing research on cancer vaccines and adoptive cell therapies holds promise for personalized and targeted treatment options. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.